Shoals Technologies Group Reports Q3 2026 Results
Shoals Technologies Group, Inc. releases its Q3 2026 report, detailing performance and strategies in the semiconductor market.
Q32 Bio Inc. Reports Q3 2026 Financial Results
Q32 Bio Inc. announces its Q3 2026 financial results, showcasing progress in drug development and financial health in the pharmaceutical preparations industry.
Odyssey Therapeutics releases Q3 results, highlights growth
Odyssey Therapeutics has filed its Q3 report, showcasing financial updates and collaborations in the biological products sector.
Kyndryl Holdings reports second fiscal quarter results
Kyndryl Holdings, Inc. announces its financial results for the second fiscal quarter ended September 30, 2026, detailing performance and future outlook.
Array Technologies Reports Q3 2026 Results, Announces Merger
Array Technologies announces strong Q3 results with a record $2.6 billion order book and a merger with Shoals Technologies Group to enhance its energy solutions.
Dine Brands Global reports third quarter results with growth
Dine Brands Global, Inc. announces positive third quarter results, highlighting growth in sales for Applebee's and IHOP, and plans for future brand development.
GLOBALFOUNDRIES Reports Q3 2026 Financial Results
GLOBALFOUNDRIES Inc. has filed its Q3 2026 financial results, highlighting key performance metrics and industry trends in the semiconductor sector.
FISERV INC Reports Third-Quarter Financial Results
FISERV INC releases Q3 financial results, highlighting growth and market strategies in the business services sector.
MoonLake Immunotherapeutics Reports Q3 Results for 2026
MoonLake Immunotherapeutics files its Q3 2026 results, showcasing financial performance and operational updates in the pharmaceutical sector.
Itaú Unibanco reports board meeting results, financials approved
Itaú Unibanco Holding S.A. announces board meeting outcomes, including approval of financial statements and strong performance for 2026.
Brookfield Renewable Partners L.P. Reports Q3 2026 Results
Brookfield Renewable Partners L.P. releases its Q3 2026 results, showcasing its commitment to renewable energy and significant operational capacity.
LifeCore Biomedical reports strong Q3 results, revenue growth
LifeCore Biomedical, Inc. announces strong Q3 results with significant revenue growth, reflecting its success in the pharmaceutical preparations sector.
uniQure reports Q3 results, advances Huntington's disease therapy
uniQure N.V. announces Q3 2026 financial results, highlighting FDA priority review for AMT-130 in Huntington's disease and strong cash reserves.
Shoals Technologies reports strong Q3 results, raises outlook
Shoals Technologies Group, Inc. announces strong Q3 2026 financial results with revenue growth, increased profitability, and a positive outlook for 2027.
Viridian Therapeutics reports Q3 2026 financial results
Viridian Therapeutics announces strong Q3 2026 results, highlighting Lumvoa's success and upcoming drug submissions, signaling growth in the pharmaceutical sector.
Datadog Reports 35% Revenue Growth in Q3 2026 Results
Datadog, Inc. announces a 35% revenue growth in Q3 2026, reaching $1.20 billion, highlighting strong demand for its AI-powered observability platform.
Geron Corp reports Q3 2026 results, expands RYTELO access
Geron Corp announces strong Q3 2026 results with a 5% revenue increase for RYTELO and plans for European market expansion.
Lifecore Biomedical reports third-quarter financial results
Lifecore Biomedical announces third-quarter results with declining revenue and increased losses, while securing new projects for future growth.
SelectQuote Reports Q1 Results with $20.3M Net Loss
SelectQuote, Inc. announces its Q1 fiscal 2027 results, revealing $280M in revenue and a net loss of $20.3M as it navigates industry challenges.
Rapport Therapeutics announces Q3 2026 financial results
Rapport Therapeutics, Inc. shares Q3 2026 financial results and business highlights, signaling ongoing developments in the pharmaceutical sector.